Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)

Market Cap	2.73B +29.5%
Revenue (ttm)	337.67M -1.6%
Net Income	-50.52M
EPS	-0.21
Shares Out	239.47M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,832,369
Average Volume	4,522,705
Open	11.48
Previous Close	11.40
Day's Range	11.31 - 11.52
52-Week Range	7.23 - 15.25
Beta	0.35
RSI	43.41
Earnings Date	Mar 31, 2026

About SHE:000590

Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food in China. It operates through the Production and Sales of Traditional Chinese Medicine; Production and Sales of Western Medicine; and Other Operations segments. The company offers prescription and over-the-counter drugs, such as tonic and health-preserving drugs, cardiovascular and cerebrovascular drugs, children's nutrition drugs, cold drugs, and heat-clearing and detoxifying drugs. It also...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1956
• Employees: 1,159
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000590

Financial Performance

In 2025, SHE:000590's revenue was 337.67 million, a decrease of -1.61% compared to the previous year's 343.21 million. Losses were -50.52 million, -59.74% less than in 2024.